Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Mar 27;28(6):831-40.
doi: 10.1097/QAD.0000000000000145.

Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

Jason V Baker  1 , Katherine Huppler Hullsiek, Amrit Singh, Eleanor Wilson, Keith Henry, Ken Lichtenstein, Nur Onen, Erna Kojic, Pragna Patel, John T Brooks, Howard N Hodis, Matt Budoff, Irini Sereti; CDC SUN Study Investigators
Affiliations
Observational Study

Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

Jason V Baker et al. AIDS. .

Abstract

Background: Identifying immunologic mechanisms that contribute to premature cardiovascular disease (CVD) among HIV-positive patients will inform prevention strategies.

Methods: Coronary artery calcium (CAC) progression was studied in an HIV cohort. Immunophenotypes were measured on baseline cryopreserved peripheral blood mononuclear cells using multicolor flow cytometry. Logistic regression identified predictors of CAC progression after adjusting for traditional and HIV-related risk factors.

Results: Baseline characteristics for the analysis cohort (n=436) were median age 42 years, median CD4 cell count 481 cells/μl, and 78% receiving antiretroviral therapy. Higher frequencies of CD16 monocytes were associated with greater likelihood of CAC progression, after adjusting for traditional and HIV risk factors [odds ratio per doubling was 1.66 for CD14/CD16 (P=0.02), 1.36 for CD14/CD16 (P=0.06), and 1.69 for CD14/CD16 (P=0.01)]. Associations for CD16 monocytes persisted when restricted to participants with viral suppression. We found no significant associations for CAC progression with other cellular phenotypes, including T-cell activation and senescence markers.

Conclusion: Circulating CD16 monocytes, potentially reflecting a more pro-atherogenic subpopulation, independently predicted greater CAC progression among HIV-infected persons at low risk for AIDS. In contrast to T-cell abnormalities classically associated with AIDS-related disease progression, these data highlight the potential role of monocyte activation in HIV-related CVD risk.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: No author conflicts related to collection and presentation of these data.

Figures

Figure 1
Figure 1. Monocyte Phenotype by CAC Outcome
After gating on live cells that express HLA-DR and lack expression of markers of T, B, and NK cells (CD2, CD3, CD19, CD20, and CD56), the proportions of monocytes expressing CD14 (horizontal axis) and CD16 (vertical axis) are shown for representative patients with: A) No CAC: absent at baseline and at year 2 follow up, B) Incident CAC: absent at baseline but detectable at year 2 follow up, C) Stable CAC: detectable at baseline but without significant increase over 2 years of follow up, and D) Increased CAC: detectable at baseline with a significant increase over 2 years of follow up. The percent of cells for each quadrant are reported in the outer most corner. Greater frequencies of CD14+/CD16+ (upper right quadrant) and CD14var/CD16+ (both upper quadrants combined) are seen with subsequent CAC progression (‘B’ and ‘D’).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010;55:262–270. - PubMed
    1. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614–622. - PMC - PubMed
    1. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–2296. - PubMed
    1. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723–1735. - PubMed
    1. Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, et al. Risk Factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. CID. 2003;37:292–298. - PubMed

Publication types